We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$22.8B
AUM Growth
-$510M
Cap. Flow
-$2.26B
Cap. Flow %
-9.9%
Top 10 Hldgs %
40.08%
Holding
187
New
21
Increased
43
Reduced
39
Closed
22

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$207M
2
ANSS
Ansys
ANSS
+$201M
3
WWD icon
Woodward
WWD
+$192M
4
SWN
Southwestern Energy Company
SWN
+$168M
5
SQSP
Squarespace, Inc.
SQSP
+$130M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$294M
2
NDAQ icon
Nasdaq
NDAQ
+$256M
3
CRM icon
Salesforce
CRM
+$231M
4
AZN icon
AstraZeneca
AZN
+$188M
5
ARMK icon
Aramark
ARMK
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 31.84%
2 Technology 13.48%
3 Financials 9.84%
4 Communication Services 6.79%
5 Industrials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVCPW
151
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$71.8K ﹤0.01%
990,000
– –
IRWD icon
152
Ironwood Pharmaceuticals
IRWD
$714M
$53.6K ﹤0.01%
13,000
– –
LU icon
153
Lufax Holding
LU
$1.3B
$52.4K ﹤0.01%
15,000
– –
SLDPW icon
154
Solid Power Inc Warrant
SLDPW
$10.6M
$48.6K ﹤0.01%
405,316
– –
GATEW
155
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$48.3K ﹤0.01%
1,485,000
– –
CITEW
156
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$28K ﹤0.01%
175,000
– –
RVMDW icon
157
Revolution Medicines Inc Warrant
RVMDW
$127M
$16.8K ﹤0.01%
120,085
– –
RCFA.WS
158
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$15.1K ﹤0.01%
300,000
– –
GHIXW
159
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$14.6K ﹤0.01%
166,664
– –
NVNIW
160
Nvni Group Limited Warrants
NVNIW
$836K
$7.72K ﹤0.01%
375,000
– –
JWSM.WS
161
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$6.5K ﹤0.01%
200,000
– –
BCSAW
162
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$3K ﹤0.01%
150,000
– –
RGTIW icon
163
Rigetti Computing Warrants
RGTIW
$181M
$2.08K ﹤0.01%
22,675
– –
APLS
164
DELISTED
Apellis Pharmaceuticals
APLS
– –
-6,000
Closed -$230K
AZN icon
165
AstraZeneca
AZN
$250B
– –
-1,204,859
Closed -$188M
CRSP icon
166
CRISPR Therapeutics
CRSP
$5.17B
– –
-530,000
Closed -$28.6M
HUM icon
167
Humana
HUM
$46.2B
– –
-600
Closed -$224K
IONS icon
168
Ionis Pharmaceuticals
IONS
$9.4B
– –
-4,800
Closed -$229K
MRUS
169
DELISTED
Merus
MRUS
– –
-4,000
Closed -$237K
NRIX icon
170
Nurix Therapeutics
NRIX
$2.65B
– –
-108,799
Closed -$2.27M
PCG icon
171
PG&E
PCG
$38.5B
– –
-692,323
Closed -$12.1M
QTRX icon
172
Quanterix
QTRX
$190M
– –
-80,000
Closed -$1.06M
RIO icon
173
Rio Tinto
RIO
$164B
– –
-137,500
Closed -$9.07M
SRPT icon
174
CALL
Sarepta Therapeutics
SRPT
$1.77B
– –
-133,300
Closed -$21.1M
SYRE icon
175
Spyre Therapeutics
SYRE
$9.25B
– –
-666,000
Closed -$15.7M
4 5 6
7
8

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Farallon Capital Management held 187 positions worth $22.8B, down 2.2% from $23.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management withdrew a net $2.26B in Q3 2024, closing 22 positions and reducing 39 holdings. Its most notable exit was AstraZeneca, an estimated $188M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Woodward worth $198M.

  • Farallon Capital Management's largest Q3 2024 buy was Woodward: 1,154,000 shares worth $198M.
  • Farallon Capital Management added most to Walt Disney in Q3 2024, an estimated $207M increase.
  • Farallon Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $294M.
  • Farallon Capital Management fully exited AstraZeneca in Q3 2024, selling an estimated $188M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $22.8B portfolio in Q3 2024.
  • Farallon Capital Management opened 21 new positions and closed 22 in Q3 2024.
  • Farallon Capital Management's portfolio value fell 2.2% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.